News
The entrepreneur says biotech should be less contentious than AI, as a breakthrough in Beijing is just as usable in Boston.
Epidermolysis bullosa is a rare and severe skin disease where patients have fragile skin that blisters and tears. A Mt.
WASHINGTON — mRNA, a Nobel-winning technology harnessed by Trump officials to create Covid shots in record time, is becoming ...
2h
DPA International on MSNFrench pharma firm Sanofi in $9.5bn plan to buy Blueprint MedicinesFrench pharmaceutical and healthcare company Sanofi said on Monday it will buy US-based Blueprint Medicines. The transaction ...
The process is called extracellular respiration, which mimics how batteries discharge electric current -- allowing bacteria ...
Home-grown start-up Mirxes is going places, but co-founder is firmly rooted in Singapore. Read more at straitstimes.com. Read ...
12h
The Mobile Rundown on MSNShe Helped Build a Startup That’s Changing How We Treat DiseaseJanice Chen co-founded Mammoth Biosciences after inventing a powerful gene detection tool in grad school. Now she's helping ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...
Colossal Biosciences raises hype over the return of a lost species, but some scientists dispute this and their overall agenda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results